Showing 1 - 10 of 66
[fre] La réglementation hospitalière : tarification par pathologie ou achat de soins ? par Michel Mougeot, Florence Naegelen . De nombreux pays ont mis en place des mécanismes incitatifs pour maîtriser des dépenses de santé. La tarification par pathologie repose sur une logique de...
Persistent link: https://www.econbiz.de/10010978184
Persistent link: https://www.econbiz.de/10010978419
Persistent link: https://www.econbiz.de/10005239312
In most health care systems where a prospective payment system is implemented, an outlier payment is used to cover the hospitals' unusually high costs. When the hospital chooses its cost reduction effort before observing a patient's severity, we show that the best outlier payment is based on the...
Persistent link: https://www.econbiz.de/10005204190
In this paper, we drop the symmetry assumption in a model of first price procurement auction. We consider the case of two groups of bidders whose costs are drawn from two different uniform distributions. Conditions of existence of a common minimum bid are exhibited and bayesian equilibrium...
Persistent link: https://www.econbiz.de/10005078803
Persistent link: https://www.econbiz.de/10009210565
Dans cet article, nous considérons la mise en œuvre du critère de l'offre économiquement la plus avantageuse dans des marchés publics passés par voie électronique. Pour cela, nous analysons la procédure usuelle de l'enchère anglaise inversée avec bonus de qualité en considérant que...
Persistent link: https://www.econbiz.de/10004985355
In this paper, we analyze the prospective method of paying hospitals when the within-DRG variance is high. To avoid patients dumping, an outlier payment system is implemented. In the APDRG Swiss System, it consists in a mixture of fully prospective payments for low costs patients and partially...
Persistent link: https://www.econbiz.de/10004998463
In this article, we analyze the rationale for introducing outlier payments into a prospective payment system for hospitals under adverse selection and moral hazard. The payer has only two instruments: a fixed price for patients whose treatment cost is below a threshold <formula format="inline"><file name="jori_1293_mu1.gif" type="gif" /></formula> and a cost-sharing rule...
Persistent link: https://www.econbiz.de/10005005295
Persistent link: https://www.econbiz.de/10005108982